Search Results - "Wood, Elizabeth R."

Refine Results
  1. 1

    Two Calorimetric Glass Transitions in Miscible Blends Containing Poly(ethylene oxide) by Gaikwad, Ashish N, Wood, Elizabeth R, Ngai, To, Lodge, Timothy P

    Published in Macromolecules (08-04-2008)
    “…Miscible blends containing poly(ethylene oxide) (PEO) have been examined over the entire composition range using differential scanning calorimetry to explore…”
    Get full text
    Journal Article
  2. 2

    Evaluation of protein quantification using standard peptides containing single conservative amino acid replacements by Remily-Wood, Elizabeth R., Koomen, John M.

    Published in Journal of mass spectrometry. (01-02-2012)
    “…ABSTRACT Structural analogs are evaluated as peptide internal standards for protein quantification with liquid chromatography‐multiple reaction monitoring mass…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Mass Spectrometry Mapping of Epidermal Growth Factor Receptor Phosphorylation Related to Oncogenic Mutations and Tyrosine Kinase Inhibitor Sensitivity by Zhang, Guolin, Fang, Bin, Liu, Richard Z, Lin, Huiyi, Kinose, Fumi, Bai, Yun, Oguz, Umut, Remily-Wood, Elizabeth R, Li, Jiannong, Altiok, Soner, Eschrich, Steven, Koomen, John, Haura, Eric B

    Published in Journal of proteome research (07-01-2011)
    “…The epidermal growth factor receptor (EGFR) plays an important role in cancer by activating downstream signals important in growth and survival. Inhibitors of…”
    Get full text
    Journal Article
  5. 5

    Proteomic Contributions to Personalized Cancer Care by Koomen, John M., Haura, Eric B., Bepler, Gerold, Sutphen, Rebecca, Remily-Wood, Elizabeth R., Benson, Kaaron, Hussein, Mohamad, Hazlehurst, Lori A., Yeatman, Timothy J., Hildreth, Lynne T., Sellers, Thomas A., Jacobsen, Paul B., Fenstermacher, David A., Dalton, William S.

    Published in Molecular & cellular proteomics (01-10-2008)
    “…Cancer impacts each patient and family differently. Our current understanding of the disease is primarily limited to clinical hallmarks of cancer, but many…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Quantitative proteomics of breast tumors: Tissue quality assessment to clinical biomarkers by Chen, Yi, Britton, David, Wood, Elizabeth R., Brantley, Stephen, Magliocco, Anthony, Pike, Ian, Koomen, John M.

    Published in Proteomics (Weinheim) (01-03-2017)
    “…Liquid chromatography‐selected reaction monitoring mass spectrometry (LC‐SRM) is not only a proven tool for clinical chemistry, but also a versatile method to…”
    Get full text
    Journal Article
  9. 9

    Two calorimetric glass transitions do not necessarily indicate immiscibility: The case of PEO/PMMA by Lodge, Timothy P., Wood, Elizabeth R., Haley, Jeffrey C.

    “…Differential scanning calorimetry has been used to examine blends of a poly(ethylene oxide) (PEO), Mn = 300 g/mol, and a poly(methylmethacrylate) (PMMA), Mn =…”
    Get full text
    Journal Article
  10. 10

    Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors by Chen, Yi, Britton, David, Wood, Elizabeth R, Brantley, Stephen, Fournier, Michelle, Wloch, Marek, Williams, Vonetta L, Johnson, Joseph, Magliocco, Anthony, Pike, Ian, Koomen, John M

    “…Liquid chromatography-selected reaction monitoring (LC-SRM) mass spectrometry has developed into a versatile tool for quantification of proteins with a wide…”
    Get more information
    Journal Article
  11. 11

    Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins by Chen, Yi, Fisher, Kate J, Lloyd, Mark, Wood, Elizabeth R, Coppola, Domenico, Siegel, Erin, Shibata, David, Chen, Yian A, Koomen, John M

    “…Quantitative evaluation of protein expression across multiple cancer-related signaling pathways (e.g., Wnt/β-catenin, TGF-β, receptor tyrosine kinases (RTK),…”
    Get more information
    Journal Article
  12. 12

    Variation in Stem Taper and Growth Traits in a Clonal Trial of Loblolly Pine by Wood, Elizabeth R., Bullock, Bronson P., Isik, Fikret, McKeand, Steven E.

    Published in Forest science (01-02-2015)
    “…As volume is the primary measure of value in loblolly pine (Pinus taeda L.) stands, knowledge about the stem taper of commonly deployed clones may better…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells by Fedorenko, I V, Abel, E V, Koomen, J M, Fang, B, Wood, E R, Chen, Y A, Fisher, K J, Iyengar, S, Dahlman, K B, Wargo, J A, Flaherty, K T, Sosman, J A, Sondak, V K, Messina, J L, Gibney, G T, Smalley, K S M

    Published in Oncogene (10-03-2016)
    “…The mechanisms by which some melanoma cells adapt to Serine/threonine-protein kinase B-Raf (BRAF) inhibitor therapy are incompletely understood. In the present…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Abstract 2494: Liquid chromatography-multiple reaction monitoring mass spectrometry biomarker quantification for breast cancer patient assessment by Chen, Yi, Britton, David J., Wood, Elizabeth R., Magliocco, Anthony M., Pike, Ian, Koomen, John M.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Introduction: A quantitative mass spectrometry platform has been developed for measuring biomarkers of protein expression and phosphorylation in breast cancer…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Abstract 4810: Multiplexed immunoprecipitation-liquid chromatography-multiple reaction monitoring mass spectrometry quantification of protein expression and phosphorylation for breast cancer biomarkers by Chen, Yi, Britton, David J., Wood, Elizabeth R., Pike, Ian, Koomen, John M.

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Introduction: Estrogen receptor alpha (ER alpha), progesterone receptor B (PR B), and the receptor tyrosine kinase, Her2, are tumor markers classified by the…”
    Get full text
    Journal Article
  19. 19

    Abstract 1614: Kinases in lung squamous cell carcinoma and inhibitor matching using quantitative activity-based protein profiling by Fang, Bin, Wood, Elizabeth R., Li, Jiannong, Chen, Y. Ann, Brantley, Stephen G., Kinose, Fumi, Guan, Wei, Myers, Andrew R., Eschrich, Steven A., Haura, Eric B., Koomen, John M.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Introduction: Squamous cell carcinoma (SCC) of the lung is an aggressive tumor even at an early stage, leading to poor patient outcomes. Furthermore, few…”
    Get full text
    Journal Article
  20. 20

    Abstract 5123: A platform for examining the molecular basis for targeted therapy selection in colon cancer by Chen, Yi, Wood, Elizabeth R., Chen, Yian A., Coppola, Domenico, Siegel, Erin, Shibata, David, Koomen, John M.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Introduction: The quantitative evaluation of expression and post-translational modification of receptor tyrosine kinase targets in tumor tissues may enable the…”
    Get full text
    Journal Article